During the past decade, Irvine Center for Clinical Research conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 29 clinical trials were completed, i.e. on average, 60.4% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 22 clinical trials were completed. i.e. 95.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Irvine Center for Clinical Research" #1 sponsor was "Eli Lilly and Company" with 17 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "Naurex, Inc, an affiliate of Allergan plc" with 4 trials sponsored, "Allergan" with 3 trials sponsored and "AstraZeneca" with 3 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Irvine Center for Clinical Research" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Banner Alzheimer's Institute" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Irvine Center for Clinical Research" are "Alzheimer Disease" (15 trials), "Depressive Disorder, Major" (7 trials), "Alzheimer's Disease" (4 trials), "Major Depressive Disorder" (3 trials) and "Mild Cognitive Impairment" (3 trials). Many other conditions were trialed in "Irvine Center for Clinical Research" in a lesser frequency.

Most popular intervention types in "Irvine Center for Clinical Research" are "Drug" (57 trials), "Other" (6 trials), "Biological" (3 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (34 trials), "Donanemab" (4 trials), "Rapastinel" (4 trials), "LY3016859" (3 trials) and "Aticaprant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Irvine Center for Clinical Research" are 58 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Irvine Center for Clinical Research". undefined are not yet recruiting, 9 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Irvine Center for Clinical Research, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Irvine Center for Clinical Research, 1 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".